Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2748462 | Best Practice & Research Clinical Anaesthesiology | 2012 | 11 Pages |
Abstract
A left ventricular assist device (LVAD) is an important treatment option for a patient with end-stage heart failure. Both continuous and non-pulsatile devices are available, each with different effects on a patient's physiology. In general, these effects are not clinically significant with the exception of bleeding events which are more common with continuous-flow devices in some series. Both devices increase survival beyond medical management. Continuous-flow devices are smaller and are associated with less overall morbidity than pulsatile devices.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Gabriel Loor, Gonzalo Gonzalez-Stawinski,